MRNA Jun 2024 112.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:06PM EDT. Market open.
| Previous close | 0.2400 |
| Open | 0.4900 |
| Bid | 0.0800 |
| Ask | 0.4700 |
| Strike | 112.00 |
| Expiry date | 2024-06-28 |
| Day's range | 0.2200 - 0.5200 |
| Contract range | N/A |
| Volume | |
| Open interest | 53 |
Investor's Business DailyIs Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Moderna stock is trading sideways despite a bevy of news, including FDA approval for its RSV vaccine. Is MRNA stock a buy right now?
BenzingaCovid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
AstraZeneca PLC (NASDAQ: AZN) kicked off the week by receiving approval from the U.S. Food and Drug Administration for its blockbuster cancer drug Imfinzi combined with chemotherapy being used as a treatment forpatients suffering from specific type of endometrial cancer. Its pharma peer, BioNTech SE (NASDAQ: BNTX) wasn’t as lucky as also on Monday, the FDA put its experimental cancer drug study on partial clinical hold. Combining Immunotherapy And Chemotherapy Is Emerging As A New Standard In Ca
ZacksModerna (MRNA) Stock Declines While Market Improves: Some Information for Investors
Moderna (MRNA) concluded the recent trading session at $137.90, signifying a -1.52% move from its prior day's close.
© 2024 Yahoo. All rights reserved.